Literature DB >> 2744019

A case of combined Farber and Sandhoff disease.

C Fusch1, R Huenges, H W Moser, A C Sewell, W Roggendorf, B Kustermann-Kuhn, A Poulos, W F Carey, K Harzer.   

Abstract

We describe a patient with the biochemically established combination of Farber and Sandhoff disease. A 6-month-old girl of consanguineous Turkish parents presented with hoarseness, stridor, scattered skin nodules, painful swelling of hand joints and ankles, and cherry-red macular spots. Until the age of 2 years her motor and physical condition deteriorated distinctly, however her mental state remained unchanged. A biopsied skin nodule disclosed lysosomal inclusions within storage cells that were typical of Farber disease (curved tubular structures). However, other inclusions (e.g. zebra bodies) were also found. Biochemical findings included ceramide accumulation in skin nodules and cultured fibroblasts, impaired ceramide degradation on loading of cultured fibroblasts with radioactive sphingomyelin, profoundly decreased ceramidase activity in fibroblasts as well as total beta-hexosaminidase activity in fibroblasts and serum, absent hexosaminidase A and B bands on cellogel zymograms, increased urinary oligosaccharide excretion of the Sandhoff disease type, and a partial reduction of ceramidase and total beta-hexosaminidase activities in fibroblasts from her father. A diagnosis of combined Farber and Sandhoff disease was made. The effect of both enzyme deficiencies on the clinical manifestations in this patient and the genetic basis of this combination require further studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744019     DOI: 10.1007/bf00441558

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  A specific ultrastructural marker for disseminated lipogranulomatosis (Faber).

Authors:  C Schmoeckel; M Hohlfed
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

2.  Farber's disease. Light and electron microscopic study of the eye.

Authors:  M A Zarbin; W R Green; H W Moser; S J Morton
Journal:  Arch Ophthalmol       Date:  1985-01

3.  Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts.

Authors:  J T Dulaney; A Milunsky; J B Sidbury; N Hobolth; H W Moser
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

4.  An improved thin-layer chromatographic method for urinary oligosaccharide screening.

Authors:  A C Sewell
Journal:  Clin Chim Acta       Date:  1979-03-15       Impact factor: 3.786

5.  Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.

Authors:  B Kustermann-Kuhn; K Harzer
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Farber's disease in two siblings, sural nerve and subcutaneous biopsies by light and electron microscopy.

Authors:  J F Pellissier; M Berard-Badier; N Pinsard
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

7.  Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates.

Authors:  H J Kytzia; U Hinrichs; K Sandhoff
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.

Authors:  U Burck; H W Moser; H H Goebel; R Grüttner; K R Held
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

9.  Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.

Authors:  T Kudoh; D A Wenger
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  Ganglioside storage, hexosaminidase lability, and urinary oligosaccharides in adult Sandhoff's disease.

Authors:  P A Bolhuis; J G Oonk; P E Kamp; A J Ris; J C Michalski; B Overdijk; A J Reuser
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

  10 in total
  12 in total

1.  Clinical and biochemical observations in a patient with combined Pompe disease and cblC mutation.

Authors:  F A Wijburg; D S Rosenblatt; G D Vos; J W Oorthuys; L G van't Hek; B J Poorthuis; M K Sanders; R B Schutgens
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 2.  Farber disease: an ultrastructural study. Report of a case and review of the literature.

Authors:  L Zappatini-Tommasi; C Dumontel; P Guibaud; C Girod
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease.

Authors:  Carmen Bedia; Luz Camacho; José Luís Abad; Gemma Fabriàs; Thierry Levade
Journal:  J Lipid Res       Date:  2010-09-24       Impact factor: 5.922

4.  Accumulation of ordered ceramide-cholesterol domains in farber disease fibroblasts.

Authors:  Natalia Santos Ferreira; Michal Goldschmidt-Arzi; Helena Sabanay; Judith Storch; Thierry Levade; Maria Gil Ribeiro; Lia Addadi; Anthony H Futerman
Journal:  JIMD Rep       Date:  2013-07-12

5.  Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.

Authors:  B Schmid; B C Paton; K Sandhoff; K Harzer
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

6.  Rare Diseases in Glycosphingolipid Metabolism.

Authors:  Hongwen Zhou; Zhoulu Wu; Yiwen Wang; Qinyi Wu; Moran Hu; Shuai Ma; Min Zhou; Yan Sun; Baowen Yu; Jingya Ye; Wanzi Jiang; Zhenzhen Fu; Yingyun Gong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 7.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.

Authors:  K Harzer; B C Paton; A Poulos; B Kustermann-Kuhn; W Roggendorf; T Grisar; M Popp
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

8.  A family with combined Farber and Sandhoff, isolated Sandhoff and isolated fetal Farber disease: postnatal exclusion and prenatal diagnosis of Farber disease using lipid loading tests on intact cultured cells.

Authors:  T Levade; H Enders; M Schliephacke; K Harzer
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

9.  Farber disease: clinical presentation, pathogenesis and a new approach to treatment.

Authors:  Karoline Ehlert; Michael Frosch; Natalja Fehse; Axel Zander; Johannes Roth; Josef Vormoor
Journal:  Pediatr Rheumatol Online J       Date:  2007-06-29       Impact factor: 3.054

Review 10.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.